论文部分内容阅读
目的探讨氨溴索与参麦注射液联合应用治疗慢性阻塞性肺病的临床治疗效果。方法选取2011年7月-2011年11月于我院治疗的慢性阻塞性肺病患者76例为研究对象,随机分为两组,一组40例,为实验组(氨溴索与参麦注射液联合应用),一组36例为对照组(单纯氨溴索组),记录两组患者治疗前后的肺功能检测指标的变化,最后进行组内及组间的比较。结果治疗前后,两组患者肺功能的改善的程度较治疗前均有明显提高,实验组肺功能改善程度与对照组相比差异显著,P均小于0.05。结论氨溴索与参麦注射液联合应用治疗慢性阻塞性肺病的治疗效果好,可以在临床推广应用。
Objective To investigate the clinical effect of ambroxol and shenmai injection in treating chronic obstructive pulmonary disease. Methods Seventy-six patients with chronic obstructive pulmonary disease (COPD) treated in our hospital from July 2011 to November 2011 were selected as study subjects and randomly divided into two groups, 40 cases in each group. The experimental group (ambroxol and Shenmai injection A group of 36 cases for the control group (simple ambroxol group), the two groups of patients before and after treatment to record changes in lung function tests, and finally for intra-and inter-group comparisons. Results Before and after treatment, the improvement of pulmonary function in both groups was significantly improved compared with those before treatment. The improvement of pulmonary function in experimental group was significantly different from that in control group (P <0.05). Conclusion The combination of ambroxol and Shenmai injection in the treatment of chronic obstructive pulmonary disease has a good therapeutic effect and can be widely applied in clinic.